Keros Therapeutics, Inc. (KROS)

19.55 +0.05 (+0.26%) USD  |  NASDAQ  |  Jan 14, 15:05
More

Keros Therapeutics Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Innoviva, Inc. Upgrade
Ocugen, Inc. Upgrade
Bionano Genomics, Inc. Upgrade